跳至主要内容
临床试验/IRCT201011135161N1
IRCT201011135161N1已完成未知

Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy

Vice-chancellor for Research Affairs, Shiraz University of Medical Sciences0 个研究点目标入组 199 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
199

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Eligibility was defined as the age between 18 and 65 years and baseline serum creatinine=1.5 mg/dl. Exclusion criteria were acute myocardial infarction, congestive heart failure, hemodynamic instability during or after procedure, known allergy or previous administration of pentoxifylline and use of concomitant nephrotoxic agents and diuretics.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for Research Affairs, Shiraz University of Medical Sciences

相似试验

Pentoxifylline and Contrast Induced Nephropathy | 临床试验